Related Experiment Video
Updated: Jun 3, 2025
An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
Prevention and Management of Infectious Complications in Pediatric Patients With Cancer: A Survey Assessment of
Leonora R Slatnick1, David Hoogstra2, Brian T Fisher3
1Department of Pediatrics, Primary Children's Hospital, Salt Lake City, Utah, USA.
Insights
Pediatric oncology centers often follow guidelines for infection prevention, but practices for managing fever and neutropenia (FN) show significant variation. Further studies are needed to standardize care and fill evidence gaps.
Area of Science:
- Pediatric Oncology
- Infectious Diseases
- Clinical Practice Guidelines
Background:
- Clinical practice guidelines (CPGs) for pediatric oncology infection prophylaxis and management exist.
- Limited data describe actual management practices at pediatric oncology centers.
Purpose of the Study:
- To survey current infection management practices in pediatric oncology.
- To identify variations in prophylaxis and fever/neutropenia management.
Main Methods:
- Electronic survey distributed to Children's Oncology Group (COG) institutions.
- Survey focused on infection management in nontransplant pediatric oncology patients.
- One response per institution to represent institutional practices.
Main Results:
- 57% response rate achieved (129/227 institutions).
- High utilization of COG-endorsed CPGs for prophylaxis (76% antibacterial, 74% antifungal) and fever/neutropenia (FN, 64%).
- Variability noted in definitions (fever, phagocyte recovery, antibiotic duration) and management of FN, including empiric antibiotics and admission protocols.
Conclusions:
- Antimicrobial prophylaxis strategies and fever management show both consistency and substantial variability.
- Opportunities exist for implementation studies to standardize CPG application.
- Randomized trials are needed to address knowledge gaps and advance evidence in pediatric oncology infection management.
Introduction:
While clinical practice guidelines (CPGs) for pediatric oncology infection prophylaxis and management exist, few data describe actual management occurring at pediatric oncology centers.
Methods:
An electronic survey querying infection management practices in nontransplant pediatric oncology patients was iteratively created by the Children's Oncology Group (COG) Cancer Control and Supportive Care Infectious Diseases Subcommittee and sent to leaders at all COG institutions, limiting each site to one response to represent their institution.
Results:
The response rate was 57% (129/227 institutions). Many sites reported utilizing COG-endorsed CPGs for antibacterial (76%) and antifungal prophylaxis (74%), and fever and neutropenia (FN, 64%). Most institutions reported using antimicrobial prophylaxis for patients with acute myeloid leukemia (88% antibacterial, 100% antifungal) and relapsed acute lymphoblastic leukemia (82% antibacterial, 95% antifungal). Definitions of fever, phagocyte recovery, and antibiotic duration in febrile patients varied. Most institutions administer empiric broad-spectrum antibiotics for nonneutropenic fever, although 14% reported withholding antibiotics based on initial clinical status or risk stratification tools. Most respondents reported (70%) admitting FN patients for at least 48 h, however 15% have low-risk FN protocols allowing outpatient management. FN patients remain admitted on antibiotics through count recovery in 50% of institutions, whereas the others employed various early discharge/early antibiotic discontinuation strategies.
Conclusions:
There is often consistency but also substantial variability in reported antimicrobial prophylaxis strategies and management of patients with fever and represents an opportunity for implementation studies to standardize application of CPG recommendations and randomized trials to advance evidence where knowledge gaps exist.
More Related Videos
10:24Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System
Published on: October 5, 2015
12:03Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
Related Concept Videos
01:22Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
01:26Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
01:25Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
01:17Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
01:20Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....